From the Department of Geriatrics (Surmeli, Atmis, Cosarderelioglu, Yalcin, Varli, Aras); from the Department of Internal Medicine (Karpuzcu), Ankara University Faculty of Medicine, Ibn-i Sina Hospital, from the Department of Gastroenterology (Karpuzcu) Etlik City Hospital, Ankara, and from the Department of Geriatrics (Aras), Istanbul Medipol Hospital, Istanbul, Turkey.
Saudi Med J. 2024 Jun;45(6):598-605. doi: 10.15537/smj.2024.45.6.20240166.
To assess the impact of sarcopenia and vitamin D levels on the severity of lower urinary tract symptoms (LUTS).
A total of 193 male patients, aged 60 years and above, who visited the geriatric outpatient clinic at Ibn-i Sina Hospital in Ankara, Turkey, between December 2019 and March 2021, were enrolled. Sarcopenia was diagnosed according to the criteria set by the European Working Group on Sarcopenia in Older People. The presence and severity of lower urinary tract symptoms were assessed using the International Prostate Symptom Score questionnaire, categorizing symptom severity as mild or moderate-to-severe.
The median patient age was 71 years (range: 66-77). Sarcopenia affected 24.9% of the population studied. Mild LUTS was observed in 43.5% and moderate-to-severe LUTS was observed in 56.5% of patients. Sarcopenia prevalence was significantly higher in the individuals with moderate-to-severe LUTS compared to those with mild-LUTS (=0.021). After adjusting for Charlson comorbidity index and age, only vitamin D levels were significantly associated with increased odds of moderate-to-severe LUTS (odds ratio [OR]=0.95, 95% confidence interval [CI]: [0.92-0.98], =0.002). Sarcopenia was not significantly associated with the severity of LUTS (OR=2.04, 95% CI: [0.94-4.45], =0.070). An inverse linear trend was observed between quartiles of 25 (OH) vitamin D and LUTS severity. As 25 (OH)vitamin D levels increased, the proportion of patients with moderate-to-severe LUTS decreased (=0.023).
Sarcopenia did not significantly impact LUTS severity, but low vitamin D levels were associated with moderate-to-severe LUTS.
评估肌少症和维生素 D 水平对下尿路症状(LUTS)严重程度的影响。
本研究共纳入 193 名 60 岁及以上的男性患者,他们于 2019 年 12 月至 2021 年 3 月期间在土耳其安卡拉 Ibn-i Sina 医院老年门诊就诊。根据欧洲老年人肌少症工作组制定的标准诊断肌少症。使用国际前列腺症状评分问卷评估下尿路症状的存在和严重程度,将症状严重程度分为轻度或中重度。
患者的中位年龄为 71 岁(范围:66-77 岁)。24.9%的研究人群患有肌少症。43.5%的患者存在轻度 LUTS,56.5%的患者存在中重度 LUTS。与轻度 LUTS 患者相比,中重度 LUTS 患者的肌少症患病率显著更高(=0.021)。在校正 Charlson 合并症指数和年龄后,只有维生素 D 水平与中重度 LUTS 的发生风险显著相关(比值比 [OR]=0.95,95%置信区间 [CI]:[0.92-0.98],=0.002)。肌少症与 LUTS 的严重程度无显著相关性(OR=2.04,95%CI:[0.94-4.45],=0.070)。25(OH)维生素 D 四分位数与 LUTS 严重程度之间呈负线性趋势。随着 25(OH)维生素 D 水平的升高,中重度 LUTS 患者的比例降低(=0.023)。
肌少症对 LUTS 严重程度无显著影响,但低维生素 D 水平与中重度 LUTS 相关。